ABBOTT LABORATORIES — Director's Dealing 2005

Mar 28, 2005

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2005-03-24

Reporting Person: WHITE MILES D (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2005-03-24	Common shares without par value	M	51695	$39.622	Acquired	652132	Direct
2005-03-24	Common shares without par value	M	267663	$32.6111	Acquired	919795	Direct
2005-03-24	Common shares without par value	F	272299	$44.60	Disposed	647496	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2005-03-24	Option (right to buy)	$39.622	M	51695	Disposed	2005-04-27	common shares (51695)	Direct
2005-03-24	Option (right to buy)	$32.6111	M	267663	Disposed	2010-02-10	common shares (267663)	Direct
2005-03-24	Option (right to buy)	$44.60	A	224097	Acquired	2010-02-10	common shares (224097)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	14994	Indirect
Common shares without par value	3713	Indirect
Common shares without par value	3713	Indirect
Common shares without par value	3713	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of March 24, 2005.

F2: The reporting person disclaims beneficial ownership of all securities held by his sons.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from 16(b) under Rule 16b-3.